McCune TR et al. |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. |
1998 |
Transplantation |
pmid:9448150
|
Mentzer RM et al. |
Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. |
1998 |
Transplantation |
pmid:9448154
|
Ernst A et al. |
Lung abcess complicating Legionella micdadei pneumonia in an adult liver transplant recipient: case report and review. |
1998 |
Transplantation |
pmid:9448158
|
Cavaillé-Coll MW and Elashoff MR |
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. |
1998 |
Transplantation |
pmid:9448161
|
Levy G et al. |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. |
2004 |
Transplantation |
pmid:15201658
|
O'Grady J |
C(2) monitoring: out of the blocks but with some way to go! |
2004 |
Transplantation |
pmid:15201659
|
Fung JJ |
Tacrolimus and transplantation: a decade in review. |
2004 |
Transplantation |
pmid:15201685
|
First MR |
Transplantation in the nineties. |
1992 |
Transplantation |
pmid:1370734
|
Ajiki T et al. |
Generation of donor hematolymphoid cells after rat-limb composite grafting. |
2003 |
Transplantation |
pmid:12640301
|
Khanafer A et al. |
Increased nitric oxide production during acute rejection in kidney transplantation: a useful marker to aid in the diagnosis of rejection. |
2007 |
Transplantation |
pmid:17876269
|
Tydén G et al. |
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. |
2007 |
Transplantation |
pmid:17496528
|
Faguer S et al. |
Rituximab therapy for acute humoral rejection after kidney transplantation. |
2007 |
Transplantation |
pmid:17496547
|
Misra S et al. |
Red cell aplasia in children on tacrolimus after liver transplantation. |
1998 |
Transplantation |
pmid:9500636
|
van Hooff JP et al. |
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. |
2003 |
Transplantation |
pmid:12829890
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
Heffron TG et al. |
Pediatric liver transplantation with daclizumab induction. |
2003 |
Transplantation |
pmid:12829908
|
Gathogo E et al. |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. |
2016 |
Transplantation |
pmid:26413990
|
Butani L et al. |
Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. |
2002 |
Transplantation |
pmid:11793001
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Demmers MW et al. |
Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells. |
2014 |
Transplantation |
pmid:24704664
|
Larsen JL et al. |
Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. |
2006 |
Transplantation |
pmid:16926589
|
Yang Z et al. |
Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. |
2003 |
Transplantation |
pmid:12589149
|
Papadopoulos-Köhn A et al. |
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. |
2015 |
Transplantation |
pmid:25208324
|
Ericzon BG et al. |
The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primate. |
1992 |
Transplantation |
pmid:1376501
|
Gonwa TA et al. |
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. |
2001 |
Transplantation |
pmid:11773892
|
Fisher RA et al. |
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9884248
|
Solez K et al. |
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9884269
|
Guo Z et al. |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. |
1997 |
Transplantation |
pmid:9075844
|
Ciancio G et al. |
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. |
1997 |
Transplantation |
pmid:9075856
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Lenaers JI et al. |
Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. |
2006 |
Transplantation |
pmid:17102764
|
Barraclough KA et al. |
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. |
2012 |
Transplantation |
pmid:23095803
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Starzl TE et al. |
Hepatotrophic effects of FK506 in dogs. |
1991 |
Transplantation |
pmid:1702912
|
Yamamoto S et al. |
FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation. |
2004 |
Transplantation |
pmid:15591950
|
Nashan B et al. |
Clinical validation studies of Neoral C(2) monitoring: a review. |
2002 |
Transplantation |
pmid:12023607
|
Serón D et al. |
Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. |
2007 |
Transplantation |
pmid:17353788
|
Sarwal MM et al. |
Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. |
2001 |
Transplantation |
pmid:11468528
|
Camirand G et al. |
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. |
2001 |
Transplantation |
pmid:11468532
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Levitsky J et al. |
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. |
2011 |
Transplantation |
pmid:21239962
|
Araki M et al. |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. |
2006 |
Transplantation |
pmid:16477217
|
Gallon L et al. |
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. |
2006 |
Transplantation |
pmid:16477235
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Mathis AS et al. |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. |
2001 |
Transplantation |
pmid:11374405
|
Jain A et al. |
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. |
2001 |
Transplantation |
pmid:11374410
|
Neumann UP et al. |
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. |
2001 |
Transplantation |
pmid:11374419
|
Hayashi S et al. |
Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation. |
2005 |
Transplantation |
pmid:16123724
|
Chan K et al. |
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. |
2011 |
Transplantation |
pmid:21836540
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Ahsan N et al. |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. |
2001 |
Transplantation |
pmid:11477347
|
Andries S et al. |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. |
2001 |
Transplantation |
pmid:11477351
|
Kovarik JM et al. |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients. |
2011 |
Transplantation |
pmid:21157403
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Ciancio G et al. |
Review of major clinical trials with mycophenolate mofetil in renal transplantation. |
2005 |
Transplantation |
pmid:16251852
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Srinivas TR et al. |
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. |
2005 |
Transplantation |
pmid:16251854
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
Buell JF et al. |
Malignancy after transplantation. |
2005 |
Transplantation |
pmid:16251858
|
Panz VR et al. |
Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1. |
2002 |
Transplantation |
pmid:11889436
|
Charney DA et al. |
Plasma cell-rich acute renal allograft rejection. |
1999 |
Transplantation |
pmid:10515379
|
Randhawa PS et al. |
Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. |
1999 |
Transplantation |
pmid:9921801
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Oike F et al. |
A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. |
2000 |
Transplantation |
pmid:10868630
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Blakolmer K et al. |
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. |
2000 |
Transplantation |
pmid:10868635
|
Gloor JM et al. |
Subclinical rejection in tacrolimus-treated renal transplant recipients. |
2002 |
Transplantation |
pmid:12131699
|
Verleden GM et al. |
Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. |
2002 |
Transplantation |
pmid:12131703
|
Johnson C et al. |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. |
2000 |
Transplantation |
pmid:10755536
|
Ochiai T et al. |
Studies of the effects of FK506 on renal allografting in the beagle dog. |
1987 |
Transplantation |
pmid:2447688
|
Miller J et al. |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
2000 |
Transplantation |
pmid:10755543
|
Ochiai T et al. |
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. |
1987 |
Transplantation |
pmid:2447689
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Brito-Costa A et al. |
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. |
2016 |
Transplantation |
pmid:27136260
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Dean PG et al. |
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. |
2004 |
Transplantation |
pmid:15239621
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Dieterle CD et al. |
Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. |
2004 |
Transplantation |
pmid:15239622
|
Shibasaki S et al. |
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway. |
2013 |
Transplantation |
pmid:23269193
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Ricordi C et al. |
In vivo effect of FK506 on human pancreatic islets. |
1991 |
Transplantation |
pmid:1716797
|
Katz IA et al. |
Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. |
1991 |
Transplantation |
pmid:1716801
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Tricot L et al. |
Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. |
2005 |
Transplantation |
pmid:16371923
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Veenhof H et al. |
Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients. |
2017 |
Transplantation |
pmid:27906832
|
Jin L et al. |
Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. |
2018 |
Transplantation |
pmid:29319618
|
MacPhee IA and Holt DW |
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. |
2008 |
Transplantation |
pmid:18212618
|
Tourret J et al. |
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli. |
2017 |
Transplantation |
pmid:27681266
|
Hodak SP et al. |
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. |
1998 |
Transplantation |
pmid:9734501
|